SC106

SC106 is a preclinical-stage botanical compound derived from the *Aloe Barbarossa* plant, currently under development by Se-cure Pharmaceuticals. It is specifically designed for the treatment of burns and wound healing. The compound's primary therapeutic mechanism involves preventing stasis—the cessation of blood flow—in the tissue surrounding a burn injury. By inhibiting stasis formation, SC106 aims to limit the expansion of tissue damage beyond the initial site of injury, a common complication in deep second-degree and third-degree burns. This approach represents a proprietary botanical therapy intended to selectively target damaged tissue and promote recovery.

Other names

Aloe Barbarossa extract